APEA PHARMACOLOGY FINAL
EXAM REVIEW QUESTIONS AND
CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES
2026 Q&A | INSTANT DOWNLOAD
PDF
CORE DOMAINS
• Pharmacokinetics and Pharmacodynamics
• Autonomic Nervous System Pharmacology
• Cardiovascular and Renal Pharmacology
• Endocrine Pharmacology
• Antimicrobial Therapy
• Central Nervous System Agents
• Drug Interactions and Adverse Effects
• Regulatory and Ethical Prescribing
INTRODUCTION
The purpose of this comprehensive pharmacology assessment is
to evaluate the advanced practice clinician's mastery of
pharmacotherapeutics essential for safe and effective prescribing.
This examination assesses core knowledge across
pharmacokinetic principles, major drug classifications, clinically
significant drug interactions, and evidence-based prescribing
guidelines. Questions are structured as multiple-choice and
scenario-based items designed to simulate real-world clinical
,decision-making. Emphasis is placed on applied professional
knowledge, regulatory compliance, ethical considerations, and
critical thinking necessary for optimizing patient outcomes and
minimizing adverse drug events.
SECTION ONE: QUESTIONS 1–100
1. Which of the following best describes the primary site of
drug metabolism in the human body?
A. Kidneys
B. Liver
C. Lungs
D. Plasma
B. Liver
RATIONALE: The liver is the principal organ for drug
metabolism (biotransformation), primarily through the
cytochrome P450 enzyme system. While other tissues have some
metabolic capacity, hepatic metabolism is the primary route for
converting lipophilic drugs into more water-soluble compounds
suitable for excretion.
2. A patient receiving lisinopril reports a persistent, dry
cough. Which mechanism best explains this adverse
effect?
A. Increased dopamine receptor blockade
B. Accumulation of bradykinin
C. Antagonism of beta-adrenergic receptors
D. Sodium and water retention
B. Accumulation of bradykinin
, RATIONALE: ACE inhibitors such as lisinopril decrease the
degradation of bradykinin, leading to its accumulation in the lungs
and resulting in a dry, nonproductive cough. This is a class-
specific adverse effect unrelated to beta-blockade or sodium
retention.
3. Which antibiotic class poses a significant risk for tendon
rupture, particularly in older adults or those concurrently
taking corticosteroids?
A. Macrolides
B. Cephalosporins
C. Fluoroquinolones
D. Tetracyclines
C. Fluoroquinolones
RATIONALE: Fluoroquinolones like ciprofloxacin and
levofloxacin interfere with collagen synthesis and can predispose
patients to tendinopathy and tendon rupture, especially in high-
risk populations including older adults, transplant recipients, and
those on concomitant corticosteroid therapy.
4. What is the primary mechanism of action of metformin
in the management of type 2 diabetes mellitus?
A. Direct stimulation of insulin release from pancreatic beta cells
B. Decreased hepatic glucose production and increased peripheral
insulin sensitivity
C. Delay of intestinal carbohydrate absorption
D. Inhibition of SGLT2 glucose reabsorption in the kidney
B. Decreased hepatic glucose production and increased
peripheral insulin sensitivity
RATIONALE: Metformin primarily decreases hepatic
gluconeogenesis and improves peripheral insulin sensitivity. It
, does not stimulate insulin secretion and thus rarely leads to
hypoglycemia when used as monotherapy.
5. Which drug class is absolutely contraindicated in
patients taking nitrates due to the risk of severe,
refractory hypotension?
A. Alpha-blockers
B. PDE-5 inhibitors
C. Beta-blockers
D. Calcium channel blockers
B. PDE-5 inhibitors
RATIONALE: PDE-5 inhibitors (e.g., sildenafil, tadalafil)
potentiate nitric oxide-mediated vasodilation. Concurrent use with
nitrates can cause life-threatening hypotension and is therefore
contraindicated.
6. A 72-year-old male with heart failure is initiated on
digoxin. Which of the following is an early clinical sign of
digoxin toxicity?
A. Bradycardia and visual disturbances
B. Diarrhea with hypertension
C. Hypoglycemia and tremor
D. Ataxia with hyperreflexia
A. Bradycardia and visual disturbances
RATIONALE: Early digoxin toxicity manifests as bradycardia,
nausea, vomiting, and characteristic visual disturbances such as
xanthopsia (yellow-tinged vision) or halos around lights. These
symptoms warrant immediate assessment of serum digoxin levels
and electrolytes.
EXAM REVIEW QUESTIONS AND
CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES
2026 Q&A | INSTANT DOWNLOAD
CORE DOMAINS
• Pharmacokinetics and Pharmacodynamics
• Autonomic Nervous System Pharmacology
• Cardiovascular and Renal Pharmacology
• Endocrine Pharmacology
• Antimicrobial Therapy
• Central Nervous System Agents
• Drug Interactions and Adverse Effects
• Regulatory and Ethical Prescribing
INTRODUCTION
The purpose of this comprehensive pharmacology assessment is
to evaluate the advanced practice clinician's mastery of
pharmacotherapeutics essential for safe and effective prescribing.
This examination assesses core knowledge across
pharmacokinetic principles, major drug classifications, clinically
significant drug interactions, and evidence-based prescribing
guidelines. Questions are structured as multiple-choice and
scenario-based items designed to simulate real-world clinical
,decision-making. Emphasis is placed on applied professional
knowledge, regulatory compliance, ethical considerations, and
critical thinking necessary for optimizing patient outcomes and
minimizing adverse drug events.
SECTION ONE: QUESTIONS 1–100
1. Which of the following best describes the primary site of
drug metabolism in the human body?
A. Kidneys
B. Liver
C. Lungs
D. Plasma
B. Liver
RATIONALE: The liver is the principal organ for drug
metabolism (biotransformation), primarily through the
cytochrome P450 enzyme system. While other tissues have some
metabolic capacity, hepatic metabolism is the primary route for
converting lipophilic drugs into more water-soluble compounds
suitable for excretion.
2. A patient receiving lisinopril reports a persistent, dry
cough. Which mechanism best explains this adverse
effect?
A. Increased dopamine receptor blockade
B. Accumulation of bradykinin
C. Antagonism of beta-adrenergic receptors
D. Sodium and water retention
B. Accumulation of bradykinin
, RATIONALE: ACE inhibitors such as lisinopril decrease the
degradation of bradykinin, leading to its accumulation in the lungs
and resulting in a dry, nonproductive cough. This is a class-
specific adverse effect unrelated to beta-blockade or sodium
retention.
3. Which antibiotic class poses a significant risk for tendon
rupture, particularly in older adults or those concurrently
taking corticosteroids?
A. Macrolides
B. Cephalosporins
C. Fluoroquinolones
D. Tetracyclines
C. Fluoroquinolones
RATIONALE: Fluoroquinolones like ciprofloxacin and
levofloxacin interfere with collagen synthesis and can predispose
patients to tendinopathy and tendon rupture, especially in high-
risk populations including older adults, transplant recipients, and
those on concomitant corticosteroid therapy.
4. What is the primary mechanism of action of metformin
in the management of type 2 diabetes mellitus?
A. Direct stimulation of insulin release from pancreatic beta cells
B. Decreased hepatic glucose production and increased peripheral
insulin sensitivity
C. Delay of intestinal carbohydrate absorption
D. Inhibition of SGLT2 glucose reabsorption in the kidney
B. Decreased hepatic glucose production and increased
peripheral insulin sensitivity
RATIONALE: Metformin primarily decreases hepatic
gluconeogenesis and improves peripheral insulin sensitivity. It
, does not stimulate insulin secretion and thus rarely leads to
hypoglycemia when used as monotherapy.
5. Which drug class is absolutely contraindicated in
patients taking nitrates due to the risk of severe,
refractory hypotension?
A. Alpha-blockers
B. PDE-5 inhibitors
C. Beta-blockers
D. Calcium channel blockers
B. PDE-5 inhibitors
RATIONALE: PDE-5 inhibitors (e.g., sildenafil, tadalafil)
potentiate nitric oxide-mediated vasodilation. Concurrent use with
nitrates can cause life-threatening hypotension and is therefore
contraindicated.
6. A 72-year-old male with heart failure is initiated on
digoxin. Which of the following is an early clinical sign of
digoxin toxicity?
A. Bradycardia and visual disturbances
B. Diarrhea with hypertension
C. Hypoglycemia and tremor
D. Ataxia with hyperreflexia
A. Bradycardia and visual disturbances
RATIONALE: Early digoxin toxicity manifests as bradycardia,
nausea, vomiting, and characteristic visual disturbances such as
xanthopsia (yellow-tinged vision) or halos around lights. These
symptoms warrant immediate assessment of serum digoxin levels
and electrolytes.
